Is Very High Thyroid Stimulating Hormone Level Required in Differentiated Thyroid Cancer for Ablation Success

作者: Zekiye Hasbek , Bülent Turgut

DOI: 10.4274/MIRT.88598

关键词:

摘要: OBJECTIVE Remnant ablation with radioactive iodine (I-131) is a successful form of treatment that aims to destroy the remaining residual tissue and/or metastatic after total thyroidectomy in differentiated thyroid cancer (DTC) patients. High level stimulating hormone (TSH) (≥30 mIU/L) recommended for success treatment. In this retrospective study, our aim was investigate whether TSH levels at time effect remnant ablation. METHODS Patients who were diagnosed DTC, treated bilateral total/near and referred I-131 included study. undetectable TSH-stimulated serum thyroglobulin (Tg) level, normal physical examination, negative results on whole body scan I-131, no evidence neck lymph node metastasis ultrasound defined as disease-free. The correlation between assessed. RESULTS Two hundred sixty one consecutive patients present Mean 19.47±6 mIU/L 34 <30 mIU/L, while mean 73.65±27 227 ≥30 during Ablation unsuccessful only patient had lung metastasis. 5.1% mIU/L. not significant (p=0.472). CONCLUSION conclusion, we think high alone factor Age, presence metastasis, extent mass should also be considered. Especially, tissue, obtaining adequate increase always possible. lower elevations may sufficient patients, long-term hypothyroidism required.

参考文章(17)
Reyna Sánchez, Ana Laura Espinosa-de-los-Monteros, Victoria Mendoza, Eduardo Brea, Irma Hernández, Ernesto Sosa, Moisés Mercado, Adequate thyroid-stimulating hormone levels after levothyroxine discontinuation in the follow-up of patients with well-differentiated thyroid carcinoma. Archives of Medical Research. ,vol. 33, pp. 478- 481 ,(2002) , 10.1016/S0188-4409(02)00394-6
Nadia Sawicka-Gutaj, Aleksandra Klimowicz, Jerzy Sowinski, Robert Oleksa, Maria Gryczynska, Anna Wyszomirska, Agata Czarnywojtek, Marek Ruchala, Pyramidal lobe decreases endogenous TSH stimulation without impact on radio-iodine therapy outcome in patients with differentiated thyroid cancer. Annales D Endocrinologie. ,vol. 75, pp. 141- 147 ,(2014) , 10.1016/J.ANDO.2014.02.001
Isa Neshandar Asli, Ali Shafiepour Siahkali, Babak Shafie, Hamid Javadi, Majid Assadi, Prognostic Value of Basal Serum Thyroglobulin Levels, but Not Basal Antithyroglobulin Antibody (TgAb) Levels, in Patients With Differentiated Thyroid Cancer Molecular Imaging and Radionuclide Therapy. ,vol. 23, pp. 54- 59 ,(2014) , 10.4274/MIRT.39200
Deepa Rani, Sushma Kaisar, Sushma Awasare, Kamaldeep, Amit Abhyankar, Sandip Basu, Examining recombinant human TSH primed 131I therapy protocol in patients with metastatic differentiated thyroid carcinoma: comparison with the traditional thyroid hormone withdrawal protocol European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 41, pp. 1767- 1780 ,(2014) , 10.1007/S00259-014-2737-3
Reyes Luna, Manuel Penín, Inés Seoane, Elías Álvarez, Regina Palmeiro, Ricardo García-Mayor, Should thyroxine treatment be discontinued for four weeks before 131I thyroid ablation Endocrinología y Nutrición. ,vol. 59, pp. 227- 231 ,(2012) , 10.1016/J.ENDOEN.2012.04.012
Teresa Montesano, Cosimo Durante, Marco Attard, Umberto Crocetti, Domenico Meringolo, Rocco Bruno, Salvatore Tumino, Domenico Rubello, Adil Al-Nahhas, Marzia Colandrea, Marianna Maranghi, Laura Travascio, Giuseppe Ronga, Massimo Torlontano, Age influences TSH serum levels after withdrawal of l-thyroxine or rhTSH stimulation in patients affected by differentiated thyroid cancer. Biomedicine & Pharmacotherapy. ,vol. 61, pp. 468- 471 ,(2007) , 10.1016/J.BIOPHA.2007.04.001
Elizabeth H Hoogendoorn, Ad R Hermus, Femmie de Vegt, H Alec Ross, Andre LM Verbeek, Lambertus ALM Kiemeney, Dorine W Swinkels, Fred CGJ Sweep, Martin den Heijer, Thyroid Function and Prevalence of Anti-Thyroperoxidase Antibodies in a Population with Borderline Sufficient Iodine Intake: Influences of Age and Sex Clinical Chemistry. ,vol. 52, pp. 104- 111 ,(2006) , 10.1373/CLINCHEM.2005.055194
Bryan R. Haugen, Erik K. Alexander, Keith C. Bible, Gerard M. Doherty, Susan J. Mandel, Yuri E. Nikiforov, Furio Pacini, Gregory W. Randolph, Anna M. Sawka, Martin Schlumberger, Kathryn G. Schuff, Steven I. Sherman, Julie Ann Sosa, David L. Steward, R. Michael Tuttle, Leonard Wartofsky, 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer Thyroid. ,vol. 26, pp. 1- 133 ,(2016) , 10.1089/THY.2015.0020
Syed Zubair Hussain, Maseeh uz Zaman, Sarwar Malik, Nanik Ram, Ali Asghar, Unaib Rabbani, Nida Aftab, Najmul Islam, Preablation Stimulated Thyroglobulin/TSH Ratio as a Predictor of Successful I(131)Remnant Ablation in Patients with Differentiated Thyroid Cancer following Total Thyroidectomy. Journal of Thyroid Research. ,vol. 2014, pp. 610273- 610273 ,(2014) , 10.1155/2014/610273